BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5272329)

  • 1. Steric and electronic relationships among some hallucinogenic compounds.
    Kang S; Green JP
    Proc Natl Acad Sci U S A; 1970 Sep; 67(1):62-7. PubMed ID: 5272329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular orbital studies on the conformation of hallucinogenic indolealkylamines and related compounds. The isolated molecules and the solvent effect.
    Pullman B; Courrière P; Berthod H
    J Med Chem; 1974 Apr; 17(4):439-47. PubMed ID: 4524607
    [No Abstract]   [Full Text] [Related]  

  • 3. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
    LUDWIG AM; LEVINE J
    JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of hallucinogenic drugs.
    Sperling A
    J Chromatogr Sci; 1972 May; 10(5):268-75. PubMed ID: 4561542
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety.
    Kline TB; Benington F; Morin RD; Beaton JM
    J Med Chem; 1982 Aug; 25(8):908-13. PubMed ID: 7120280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.
    Fischer R; Goldman H
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):176-84. PubMed ID: 1233520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between activity and electronic state of hallucinogenic amphetamines.
    Kang S; Green JP
    Nature; 1970 May; 226(5246):645. PubMed ID: 5444928
    [No Abstract]   [Full Text] [Related]  

  • 8. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)].
    JACOB J; LAFILLE C; LOISEAU G; ECHINARD-GARIN P; BARTHELEMY C
    Encephale; 1964; 53():520-35. PubMed ID: 14222727
    [No Abstract]   [Full Text] [Related]  

  • 10. A new view of the structural relationship between LSD and mescaline.
    Nichols DE; Pfister WR; Yim GK; Cosgrove RJ
    Brain Res Bull; 1977; 2(3):169-71. PubMed ID: 890502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A relationship between the hallucinogenic activity of drugs and their electronic configuration.
    Snyder SH; Merril CR
    Proc Natl Acad Sci U S A; 1965 Jul; 54(1):258-66. PubMed ID: 5216361
    [No Abstract]   [Full Text] [Related]  

  • 12. Hallucinogenic plants. Various chemical substances are known to be the active hallucinogenic principles in many plants.
    Farnsworth NR
    Science; 1968 Dec; 162(3858):1086-92. PubMed ID: 4880721
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of the hallucinogenic drugs LSD-25 and mescaline on the electroretinogram.
    APTER JT; PFEIFFER CC
    Ann N Y Acad Sci; 1957 Mar; 66(3):508-13; discussion, 513-4. PubMed ID: 13425239
    [No Abstract]   [Full Text] [Related]  

  • 14. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
    Winter JC
    Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
    Van Vunakis H; Farrow JT; Gjika HB; Levine L
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1483-7. PubMed ID: 5283939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.
    Carvey P; Nausieda P; Weertz R; Klawans H
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):199-210. PubMed ID: 2748860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
    Snyder SH; Faillace L; Hollister L
    Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of the binding between LSD and a 5-HT receptor: a possible explanation for hallucinogenic activity.
    Berridge MJ; Prince WT
    Br J Pharmacol; 1974 Jun; 51(2):269-78. PubMed ID: 4375525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the conformations of hallucinogenic molecules and their correlation.
    Chothia C; Pauling P
    Proc Natl Acad Sci U S A; 1969 Aug; 63(4):1063-70. PubMed ID: 4311249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.